N. Wilking
Impact in
- Genetics top 10%
- Estrogen and related hormone effects
- Obstetrics and Gynecology top 10%
- Endometrial and Cervical Cancer Treatments
Papers in
-
- Economic and Financial Impacts of Cancer 4
- Health Systems, Economic Evaluations, Quality of Life 1
- Pharmaceutical Economics and Policy 1
- Oncology 3
- Cancer Treatment and Pharmacology 2
- Co-authors
- Lars Erik Rutqvist (1 shared paper)Tommy� Fornander (1 shared paper)Unn‐Britt Johansson (1 shared paper)Hemming Johansson (1 shared paper)Bengt Jönsson (1 shared paper)Ian Smith (1 shared paper)John Zalcberg (1 shared paper)Arne Wallgren (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Annals of Oncology (1 paper)The Breast (1 paper)Cancer Research (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- SwedenAustraliaUnited States
In The Last Decade
N. Wilking
10 papers receiving 518 citations
Peers
Comparison fields: 5 of 59
- Genetics 251
- Obstetrics and Gynecology 56
- Cancer Research 106
- Reproductive Medicine 50
- Oncology 142
Countries citing papers authored by N. Wilking
This map shows the geographic impact of N. Wilking's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Wilking with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Wilking more than expected).
Fields of papers citing papers by N. Wilking
This network shows the impact of papers produced by N. Wilking. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Wilking. The network helps show where N. Wilking may publish in the future.
Co-authors
The 25 scholars most cited alongside N. Wilking, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 399 | |
| 2 | 2007 | 77 | |
| 3 | 1996 | 30 | |
| 4 | Effects of tamoxifen on the serum levels of oestrogens and adrenocortical steroids in postmenopausal breast cancer patients. | 1982 | 13 |
| 5 | 2013 | 5 | |
| 6 | A review of breast cancer care and outcomes in 18 countries in Europe, Asia, and Latin America | 2009 | 4 |
| 7 | 2010 | 4 | |
| 8 | 2006 | 4 | |
| 9 | [High-dose chemotherapy in breast cancer. Promising results in combination with stem cell support]. | 1995 | 3 |
| 10 | 2010 | 1 | |
| 11 | 2007 | 0 |
About N. Wilking
N. Wilking is a scholar working on Economics and Econometrics, Oncology, Genetics, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 11 papers that have together received 540 indexed citations. Recurring topics across this work include Economic and Financial Impacts of Cancer (4 papers), Estrogen and related hormone effects (2 papers), Cancer Treatment and Pharmacology (2 papers), Advanced Breast Cancer Therapies (1 paper), Angiogenesis and VEGF in Cancer (1 paper), Breast Cancer Treatment Studies (1 paper), Health Systems, Economic Evaluations, Quality of Life (1 paper) and Pharmaceutical Economics and Policy (1 paper). The work is most often cited by research in Genetics (251 citations), Obstetrics and Gynecology (56 citations), Cancer Research (106 citations), Reproductive Medicine (50 citations) and Oncology (142 citations). N. Wilking has collaborated with scholars based in Sweden, Australia and United States. Frequent co-authors include Lars Erik Rutqvist, Tommy� Fornander, Unn‐Britt Johansson, Hemming Johansson, Bengt Jönsson, Ian Smith, John Zalcberg, Arne Wallgren, Kjell Carlström and M. Spielmann. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, The Breast, Cancer Research and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.